0001213900-22-075595.txt : 20221128
0001213900-22-075595.hdr.sgml : 20221128
20221128182604
ACCESSION NUMBER: 0001213900-22-075595
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221123
FILED AS OF DATE: 20221128
DATE AS OF CHANGE: 20221128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cannon Kara
CENTRAL INDEX KEY: 0001913009
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09974
FILM NUMBER: 221427614
MAIL ADDRESS:
STREET 1: 527 MADISON AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZO BIOCHEM INC
CENTRAL INDEX KEY: 0000316253
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 132866202
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
BUSINESS PHONE: 5167555500
MAIL ADDRESS:
STREET 1: ENZO BIOCHEM INC
STREET 2: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
4
1
ownership.xml
X0306
4
2022-11-23
0
0000316253
ENZO BIOCHEM INC
ENZ
0001913009
Cannon Kara
527 MADISON AVE
NEW YORK
NY
10022
0
1
0
0
Chief Operating Officer
Stock Option (to acquire Common Stock)
1.97
2022-11-23
4
A
0
200000
0
A
2023-11-23
2027-11-23
Common Stock
200000
200000
D
Stock Option (to acquire Common Stock)
2.98
2023-03-24
2027-03-24
Common Stock
87500
87500
D
Stock Option (to acquire Common Stock)
3.36
2023-02-11
2027-02-11
Common Stock
87500
87500
D
Stock Option (to acquire Common Stock)
2.63
2022-01-11
2026-01-11
Common Stock
55400
55400
D
Stock Option (to acquire Common Stock)
2.2
2021-02-24
2025-02-24
Common Stock
55400
55400
D
Stock Option (to acquire Common Stock)
2.8
2020-01-03
2024-01-03
Common Stock
52000
52000
D
Stock Option (to acquire Common Stock)
4.42
2019-07-31
2023-07-30
Common Stock
35000
35000
D
The Reporting Person was granted 200,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 23, 2023.
The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.
/s/ Kara Cannon
2022-11-28